The goal of this current guideline is to provide evidence-based answers to efficacy, safety, and tolerability questions regarding the treatment of convulsive status epilepticus and to synthesize these answers into… […]
Audience: Clinical
Diagnosis and Management of Rheumatoid Arthritis
This handout provides a reference guide for the diagnosis and management of RA in the Navajo Nation. […]
Read More… from Diagnosis and Management of Rheumatoid Arthritis
Mini Cog
The Mini-Cog test can help providers detect possible cognitive impairment in older patients. […]
Monkeypox Fact Sheet
This fact sheet is from the Johns Hopkins Center for Indigenous Health is in a printable format and explains the essential information on monkeypox. […]
Quick Screen (NIDA)
Clinician’s screening tool for drug use in medical settings. This tool guides clinicians through a series of questions to identify risky substance use in their adult patients. The accompanying resources… […]
Induction with Buprenorphine for Pregnant & Parenting Patients with SUD | December 1st 2022
In this presentation, Dr. Mishka Terplan, discusses professional recommendations on buprenorphine (and methadone) as a safe and effective treatment option during pregnancy and for parenting individuals. He presents maternal benefits of… […]
Revisiting Our Journey through the Land of Native Brilliance: Planning for the 2023 Series | November 22, 2022
The Indigenous HIV/AIDS Syndemic Strategy
One of Indigenous peoples’ strengths is our ability to understand our interdependence – with each other, the land, generations past, and those to come. This type of “big thinking” naturally… […]
New CMS 2023 guidelines for Emergency Medicine | December 19, 2022
In this session, a panel of interprofessional faculty discuss clinical documentation changes required to meet CMS 2023 guidelines for Emergency Medicine Evaluation and Management (E/M) documentation and coding. The 1-hour… […]
Read More… from New CMS 2023 guidelines for Emergency Medicine | December 19, 2022
Pharmacist Toolkit: Methamphetamine Use Disorder (AAPP)
Amphetamines and other stimulants are the second most widely used class of (illicit) drugs globally, after cannabis. This guide by the American Association of Psychiatric Pharmacists is intended to highlight… […]
Read More… from Pharmacist Toolkit: Methamphetamine Use Disorder (AAPP)